News summary

Statins promote bone anabolism in estrogen deficiency by inducing osteogenic differentiation of skeletal stem/progenitor cells

Source: Nature Aging • Published: 27 Oct 2026, 00:00

Summarized by Masters of Longevity from Nature Aging.

Atorvastatin promoted bone anabolism by inducing osteogenic differentiation of LEPR+ cells.

Statins promote bone anabolism in estrogen deficiency by inducing osteogenic differentiation of skeletal stem/progenitor cells
Key Takeaways
  • Statin use was linked to slower BMD loss in postmenopausal women.
  • Atorvastatin promoted osteogenic differentiation of LEPR+ skeletal stem cells.
  • Findings were shown in ovariectomized mice and human postmenopausal cohorts.
Read the full article at Nature Aging ↗

Continue exploring

Recommended MoL Picks

MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.